Ligand validation:5QQU

NTG: 5-(1,4-oxazepan-4-yl)pyridine-2-carbonitrile

NTG is a Ligand Of Interest in 5QQU designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QQU_NTG_A_603	25%	74%	0.184	0.818	0.38	0.62	-	-	0	0	100%	1
5QQU_NTG_B_602	18%	75%	0.19	0.771	0.35	0.62	-	-	0	0	100%	1
5QQU_NTG_A_602	10%	67%	0.243	0.749	0.52	0.74	-	-	0	0	100%	1
5QR2_NTG_A_602	3%	37%	0.247	0.602	1.07	1.45	1	1	0	0	100%	1
5RF6_NTG_A_404	5%	32%	0.289	0.684	1.69	1.12	6	2	0	0	100%	0.5
5RWL_NTG_A_901	2%	26%	0.336	0.584	1.73	1.44	4	2	0	0	100%	0.51

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.